Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | HCID 54208456 | HCID 54208456 | — |
| Reactant | 9-Chloro-3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole | HCID 68558507 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 59368251 | HCID 59368251 | 3.2% |
Reaction Steps
The title compound was prepared by following general procedure 4. To a solution of 9-chloro-3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole (100 mg, 0.42 mmol) in 50% aq. NaOH solution (5 mL) tetra n-butyl ammonium chloride (9 mg, 0.03 mmol) followed by 3-chloro-5-vinylpyridine (65 mg, 0.47 mmol) was added. The reaction mixture was heated at 60° C. for 8 h. After completion of reaction, the reaction mixture was diluted with water, extracted with ethyl acetate; the organic layer was dried over Na2SO4, and concentrated under reduced pressure. The crude product was purified by reverse phase chromatography to afford 5 mg of 9-chloro-6-(2-(5-chloropyridin-3-yl)ethyl)-3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole as the TFA salt.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08569287B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-31bd2b701c324f759f5751f530ec0d27 |
|---|
| Source note | uspto-grants-2013_10 |
|---|